stockrowInfuSystems Holdings, Inc. (INFU) vs Treace Medical Concepts, Inc. (TMCI)
- InfuSystems Holdings, Inc. INFU 13.50 −0.44%
- Treace Medical Concepts, Inc. TMCI 3.84 −8.13%
InfuSystems Holdings, Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. InfuSystems Holdings, Inc. and Treace Medical Concepts, Inc. are of similar size ($271.9M and $270.1M). Treace Medical Concepts, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 32.0×. InfuSystems Holdings, Inc. grew revenue faster over the last twelve months: 2.47% against −3.95%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −29.0%) and the higher return on invested capital (10.6% vs −43.0%). Across the 19 metrics below, InfuSystems Holdings, Inc. leads on 11 and Treace Medical Concepts, Inc. on 8.
Valuation
Profitability
| Metric | INFU | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.45% | 79.45% | 57.76% |
| Operating margin | 9.26% | (26.17%) | (15.07%) |
| Net margin | 5.96% | (28.99%) | (14.45%) |
| Free cash flow margin | 10.56% | (12.20%) | (3.88%) |
| Return on equity | 15.03% | (71.99%) | (10.35%) |
| Return on assets | 8.61% | (30.72%) | (17.26%) |
| Return on invested capital | 10.55% | (42.96%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack